Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | ESR1 | P03372 | 1/20 | 0.69 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.69 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.69 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | GGT1 | P19440 | 1/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29669847 | 1.00 | HSD17B10 (0.71) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL14972 | 0.94 | HSD17B10 (0.69) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL2338852 | 0.93 | HSD17B10 (0.63) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL789772 | 0.91 | HSD17B10 (0.61) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL2337247 | 0.91 | KDM4E (0.66) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL10705752 | 0.88 | HSD17B10 (0.71) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL5988737 | 0.88 | HSD17B10 (0.71) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL2332251 | 0.88 | HSD17B10 (0.61) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL14674298 | 0.87 | KDM4E (0.56) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL1162463 | 0.86 | KDM4E (0.69) | HSD17B10KDM4ELMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118065203-B | High-strength multi-pattern artificial turf and preparation method thereof | 洛阳康迈斯人造草坪有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-118065203-A | High-strength multi-pattern artificial turf and preparation method thereof | 洛阳康迈斯人造草坪有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-113861096-B | Indole structure-containing compound, preparation method and application thereof | 中国农业大学 | 2023-07-18 | — | — | CN | claimed |
| CN-115448911-A | Preparation method of posaconazole intermediate | 成都海博为药业有限公司 | 2022-12-09 | — | — | CN | claimed |
| WO-2022228297-A1 | ENZYMATIC PREPARATION TECHNIQUE FOR ACYL/AROYL COENZYME A | 中国医学科学院药物研究所 | 2022-11-03 | — | — | WO | claimed |
| CN-115247192-A | Enzymatic preparation technology of acyl/aroyl coenzyme A | 中国医学科学院药物研究所 | 2022-10-28 | — | — | CN | claimed |
| CN-113861096-A | Compound containing indole structure, preparation method and application thereof | 中国农业大学 | 2021-12-31 | — | — | CN | claimed |
| CN-113406242-A | Detection method of aspirin-related substances | 江苏万珺医药科技有限公司 | 2021-09-17 | — | — | CN | claimed |
| CN-109513427-A | A kind of preparation method of straw base chromium ion adsorbent | 浙江海洋大学 | 2019-03-26 | — | — | CN | claimed |
| US-9644074-B2 | Benzene polycarboxylic acid compounds and their use as drug | RINNOVATION APS (DK) | 2017-05-09 | — | — | US | claimed |
| EP-2831151-B1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDINNOVATION APS (DK) | 2016-12-14 | — | — | EP | claimed |
| US-20160017104-A1 | Benzene Polycarboxylic Acid Compounds and Their Use as Drug | RDINNOVATION APS (DK) | 2016-01-21 | — | — | US | claimed |
| EP-2831151-A1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDInnovation ApS (DK) | 2015-02-04 | — | — | EP | claimed |
| WO-2013143549-A1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDINNOVATION APS (DK) | 2013-10-03 | — | — | WO | claimed |
| WO-2008037366-A2 | SOLID STATE FORMS AB OF ACETYL SALICYLIC ACID | SCICONCEPT GMBH (DE) | 2008-04-03 | — | — | WO | claimed |
| CN-122042851-A | Liquid chromatography method for determining aspirin content in calcium chloride-based cabapilin calcium mother liquor | 山东青科农牧发展有限公司 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025072672-A2 | SLC6A19-TARGETING MODULATORY NUCLEIC ACID AGENTS | JUDO BIO, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| EP-0023559-A1 | 2-(Perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4239753-A | Composition of matter and process | THE UPJOHN COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4022889-A | Therapeutic compositions of antibiotic U-44,590 and methods for using the same | THE UPJOHN COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160017104-A1 | Benzene Polycarboxylic Acid Compounds and Their Use as Drug | PAH, HPD, PLOD2 | HSD17B10 185/4885KDM4E 561/4885LMNA 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.